parkinson glutathione oxidative ipsc crispr S-transferase: A keystone in Parkinson's disease pathogenesis and therapy In Vitro CRISPR/Cas9-Directed Gene Editing
In Vitro CRISPR Cas9 Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets Scientific Reports Using induced pluripotent stem cells for modeling Parkinson's disease CRISPR And iPSC Disease Modeling And Drug Screening Human pluripotent stem cell engineering with CRISPRCas9 for Parkinson's disease Experimental & Molecular Medicine
Pay in 4 interest-free payments of $6.15 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24



